Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 30, 2023

BUY
$98.98 - $115.74 $98 - $115
1 Added 0.02%
5,137 $594,000
Q2 2023

Jul 13, 2023

SELL
$96.34 - $112.38 $2.73 Million - $3.19 Million
-28,363 Reduced 84.67%
5,136 $528,000
Q1 2023

Apr 14, 2023

SELL
$107.32 - $113.5 $20.5 Million - $21.7 Million
-191,326 Reduced 85.1%
33,499 $3.66 Million
Q4 2022

Feb 02, 2023

SELL
$62.39 - $113.8 $445,277 - $812,190
-7,137 Reduced 3.08%
224,825 $25.6 Million
Q3 2022

Nov 08, 2022

SELL
$58.92 - $84.67 $659,079 - $947,118
-11,186 Reduced 4.6%
231,962 $14.4 Million
Q2 2022

Aug 11, 2022

SELL
$79.4 - $116.36 $756,046 - $1.11 Million
-9,522 Reduced 3.77%
243,148 $19.4 Million
Q1 2022

May 16, 2022

BUY
$86.42 - $109.81 $333,494 - $423,756
3,859 Added 1.55%
252,670 $26.6 Million
Q4 2021

Feb 04, 2022

BUY
$98.56 - $119.91 $24.5 Million - $29.8 Million
248,811 New
248,811 $26.8 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Congress Wealth Management LLC Portfolio

Follow Congress Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Congress Wealth Management LLC , based on Form 13F filings with the SEC.

News

Stay updated on Congress Wealth Management LLC with notifications on news.